Travel Vaccines Market Research Report by Composite (Combination Vaccines and Mono Vaccine), by Type (Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, and Recombinant Vector Vaccines) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Travel Vaccines Market is expected to grow from USD 5,566.63 Million in 2020 to USD 8,579.99 Million by the end of 2025.
2. The Global Travel Vaccines Market is expected to grow from EUR 4,880.92 Million in 2020 to EUR 7,523.09 Million by the end of 2025.
3. The Global Travel Vaccines Market is expected to grow from GBP 4,339.15 Million in 2020 to GBP 6,688.05 Million by the end of 2025.
4. The Global Travel Vaccines Market is expected to grow from JPY 594,100.52 Million in 2020 to JPY 915,702.39 Million by the end of 2025.
5. The Global Travel Vaccines Market is expected to grow from AUD 8,083.48 Million in 2020 to AUD 12,459.28 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Travel Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Composite, the Travel Vaccines Market studied across Combination Vaccines and Mono Vaccine.
Based on Type, the Travel Vaccines Market studied across Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, Recombinant Vector Vaccines, Subunit Vaccines, and Toxoid Vaccines.
Based on Geography, the Travel Vaccines Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Travel Vaccines Market including Abbott Laboratories, Baxter International, Dynavax Technologies Corporation, F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi S.A, Shenzhen Kangtay Biological Products Co., and Takeda Pharmaceuticals U.S.A., Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Travel Vaccines Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Travel Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Travel Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Travel Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Travel Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Travel Vaccines Market?
6. What are the modes and strategic moves considered suitable for entering the Global Travel Vaccines Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Travel Vaccines Market is expected to grow from USD 5,566.63 Million in 2020 to USD 8,579.99 Million by the end of 2025.
2. The Global Travel Vaccines Market is expected to grow from EUR 4,880.92 Million in 2020 to EUR 7,523.09 Million by the end of 2025.
3. The Global Travel Vaccines Market is expected to grow from GBP 4,339.15 Million in 2020 to GBP 6,688.05 Million by the end of 2025.
4. The Global Travel Vaccines Market is expected to grow from JPY 594,100.52 Million in 2020 to JPY 915,702.39 Million by the end of 2025.
5. The Global Travel Vaccines Market is expected to grow from AUD 8,083.48 Million in 2020 to AUD 12,459.28 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Travel Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Composite, the Travel Vaccines Market studied across Combination Vaccines and Mono Vaccine.
Based on Type, the Travel Vaccines Market studied across Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines, Inactive Vaccines, Recombinant Vector Vaccines, Subunit Vaccines, and Toxoid Vaccines.
Based on Geography, the Travel Vaccines Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Travel Vaccines Market including Abbott Laboratories, Baxter International, Dynavax Technologies Corporation, F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi S.A, Shenzhen Kangtay Biological Products Co., and Takeda Pharmaceuticals U.S.A., Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Travel Vaccines Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Travel Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Travel Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Travel Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Travel Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Travel Vaccines Market?
6. What are the modes and strategic moves considered suitable for entering the Global Travel Vaccines Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Composite Outlook
3.4. Type Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL TRAVEL VACCINES MARKET, BY COMPOSITE
6.1. Introduction
6.2. Combination Vaccines
6.3. Mono Vaccine
7. GLOBAL TRAVEL VACCINES MARKET, BY TYPE
7.1. Introduction
7.2. Attenuated Vaccines
7.3. Conjugate Vaccines
7.4. DNA Vaccines
7.5. Inactive Vaccines
7.6. Recombinant Vector Vaccines
7.7. Subunit Vaccines
7.8. Toxoid Vaccines
8. AMERICAS TRAVEL VACCINES MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC TRAVEL VACCINES MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Abbott Laboratories
12.2. Baxter International
12.3. Dynavax Technologies Corporation
12.4. F. Hoffman-La Roche Ltd.
12.5. GlaxoSmithKline plc
12.6. Merck & Co., Inc.
12.7. Pfizer Inc.
12.8. Sanofi S.A
12.9. Shenzhen Kangtay Biological Products Co.
12.10. Takeda Pharmaceuticals U.S.A., Inc.
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Composite Outlook
3.4. Type Outlook
3.5. Geography Outlook
3.6. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL TRAVEL VACCINES MARKET, BY COMPOSITE
6.1. Introduction
6.2. Combination Vaccines
6.3. Mono Vaccine
7. GLOBAL TRAVEL VACCINES MARKET, BY TYPE
7.1. Introduction
7.2. Attenuated Vaccines
7.3. Conjugate Vaccines
7.4. DNA Vaccines
7.5. Inactive Vaccines
7.6. Recombinant Vector Vaccines
7.7. Subunit Vaccines
7.8. Toxoid Vaccines
8. AMERICAS TRAVEL VACCINES MARKET
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. ASIA-PACIFIC TRAVEL VACCINES MARKET
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand
10. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. COMPETITIVE LANDSCAPE
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion
12. COMPANY USABILITY PROFILES
12.1. Abbott Laboratories
12.2. Baxter International
12.3. Dynavax Technologies Corporation
12.4. F. Hoffman-La Roche Ltd.
12.5. GlaxoSmithKline plc
12.6. Merck & Co., Inc.
12.7. Pfizer Inc.
12.8. Sanofi S.A
12.9. Shenzhen Kangtay Biological Products Co.
12.10. Takeda Pharmaceuticals U.S.A., Inc.
13. APPENDIX
13.1. Discussion Guide
13.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL TRAVEL VACCINES MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMBINATION VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL TRAVEL VACCINES MARKET SIZE, BY MONO VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL TRAVEL VACCINES MARKET SIZE, BY ATTENUATED VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL TRAVEL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL TRAVEL VACCINES MARKET SIZE, BY DNA VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL TRAVEL VACCINES MARKET SIZE, BY INACTIVE VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL TRAVEL VACCINES MARKET SIZE, BY RECOMBINANT VECTOR VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL TRAVEL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. BRAZIL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. BRAZIL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. CANADA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. CANADA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. MEXICO TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. MEXICO TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AUSTRALIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AUSTRALIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CHINA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CHINA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. INDIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. INDIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. INDONESIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. INDONESIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. JAPAN TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. JAPAN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. THAILAND TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. THAILAND TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. FRANCE TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. FRANCE TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. GERMANY TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. GERMANY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ITALY TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. ITALY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. QATAR TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. QATAR TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. RUSSIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. RUSSIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SPAIN TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SPAIN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GLOBAL TRAVEL VACCINES MARKET: SCORES
TABLE 75. GLOBAL TRAVEL VACCINES MARKET: BUSINESS STRATEGY
TABLE 76. GLOBAL TRAVEL VACCINES MARKET: PRODUCT SATISFACTION
TABLE 77. GLOBAL TRAVEL VACCINES MARKET: RANKING
TABLE 78. GLOBAL TRAVEL VACCINES MARKET: MERGER & ACQUISITION
TABLE 79. GLOBAL TRAVEL VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 80. GLOBAL TRAVEL VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 81. GLOBAL TRAVEL VACCINES MARKET: INVESTMENT & FUNDING
TABLE 82. GLOBAL TRAVEL VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 83. GLOBAL TRAVEL VACCINES MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL TRAVEL VACCINES MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMBINATION VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL TRAVEL VACCINES MARKET SIZE, BY MONO VACCINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL TRAVEL VACCINES MARKET SIZE, BY ATTENUATED VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL TRAVEL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL TRAVEL VACCINES MARKET SIZE, BY DNA VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL TRAVEL VACCINES MARKET SIZE, BY INACTIVE VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL TRAVEL VACCINES MARKET SIZE, BY RECOMBINANT VECTOR VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL TRAVEL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TOXOID VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. BRAZIL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. BRAZIL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. CANADA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. CANADA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. MEXICO TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. MEXICO TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. AUSTRALIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. AUSTRALIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. CHINA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CHINA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. INDIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. INDIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. INDONESIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. INDONESIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. JAPAN TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. JAPAN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. THAILAND TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. THAILAND TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. FRANCE TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. FRANCE TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. GERMANY TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. GERMANY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ITALY TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. ITALY TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. QATAR TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. QATAR TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. RUSSIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. RUSSIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SPAIN TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SPAIN TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. GLOBAL TRAVEL VACCINES MARKET: SCORES
TABLE 75. GLOBAL TRAVEL VACCINES MARKET: BUSINESS STRATEGY
TABLE 76. GLOBAL TRAVEL VACCINES MARKET: PRODUCT SATISFACTION
TABLE 77. GLOBAL TRAVEL VACCINES MARKET: RANKING
TABLE 78. GLOBAL TRAVEL VACCINES MARKET: MERGER & ACQUISITION
TABLE 79. GLOBAL TRAVEL VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 80. GLOBAL TRAVEL VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 81. GLOBAL TRAVEL VACCINES MARKET: INVESTMENT & FUNDING
TABLE 82. GLOBAL TRAVEL VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 83. GLOBAL TRAVEL VACCINES MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL TRAVEL VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TRAVEL VACCINES MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL TRAVEL VACCINES MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2020 (USD MILLION)
FIGURE 5. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL TRAVEL VACCINES MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL TRAVEL VACCINES MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL TRAVEL VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2020 VS 2025 (%)
FIGURE 14. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2025
FIGURE 16. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL TRAVEL VACCINES MARKET SIZE, BY MONO VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 19. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2025
FIGURE 21. GLOBAL TRAVEL VACCINES MARKET SIZE, BY ATTENUATED VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL TRAVEL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL TRAVEL VACCINES MARKET SIZE, BY DNA VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL TRAVEL VACCINES MARKET SIZE, BY INACTIVE VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL TRAVEL VACCINES MARKET SIZE, BY RECOMBINANT VECTOR VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL TRAVEL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TOXOID VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 28. AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 29. AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 31. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. BRAZIL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. CANADA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. MEXICO TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 37. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 39. AUSTRALIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. CHINA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. INDIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. INDONESIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. JAPAN TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. THAILAND TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 49. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 51. FRANCE TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. GERMANY TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. ITALY TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. QATAR TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. RUSSIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. SPAIN TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. GLOBAL TRAVEL VACCINES MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 63. GLOBAL TRAVEL VACCINES MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 64. GLOBAL TRAVEL VACCINES MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 65. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TRAVEL VACCINES MARKET, BY TYPE
FIGURE 1. GLOBAL TRAVEL VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL TRAVEL VACCINES MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL TRAVEL VACCINES MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2020 (USD MILLION)
FIGURE 5. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL TRAVEL VACCINES MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL TRAVEL VACCINES MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL TRAVEL VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2020 VS 2025 (%)
FIGURE 14. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMPOSITE, 2025
FIGURE 16. GLOBAL TRAVEL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL TRAVEL VACCINES MARKET SIZE, BY MONO VACCINE, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 19. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TRAVEL VACCINES MARKET SIZE, BY TYPE, 2025
FIGURE 21. GLOBAL TRAVEL VACCINES MARKET SIZE, BY ATTENUATED VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL TRAVEL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL TRAVEL VACCINES MARKET SIZE, BY DNA VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL TRAVEL VACCINES MARKET SIZE, BY INACTIVE VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL TRAVEL VACCINES MARKET SIZE, BY RECOMBINANT VECTOR VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL TRAVEL VACCINES MARKET SIZE, BY SUBUNIT VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL TRAVEL VACCINES MARKET SIZE, BY TOXOID VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 28. AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 29. AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 31. ARGENTINA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. BRAZIL TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. CANADA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. MEXICO TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. UNITED STATES TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 37. ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 39. AUSTRALIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. CHINA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. INDIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. INDONESIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. JAPAN TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. MALAYSIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. PHILIPPINES TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. SOUTH KOREA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. THAILAND TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 49. EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 51. FRANCE TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. GERMANY TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. ITALY TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. NETHERLANDS TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. QATAR TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. RUSSIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SAUDI ARABIA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SOUTH AFRICA TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. SPAIN TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. UNITED ARAB EMIRATES TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. UNITED KINGDOM TRAVEL VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 62. GLOBAL TRAVEL VACCINES MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 63. GLOBAL TRAVEL VACCINES MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 64. GLOBAL TRAVEL VACCINES MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 65. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TRAVEL VACCINES MARKET, BY TYPE
